Inflammation-Induced Colon Cancer Stopped In Its Tracks By TNF-Alpha Antagonist

Main Category: GastroIntestinal / Gastroenterology
Also Included In: Colorectal Cancer;  Biology / Biochemistry
Article Date: 25 Jan 2008 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:4 stars

4 (1 votes)


Individuals with the inflammatory bowel disease ulcerative colitis are at increased risk of developing colon cancer. New data generated by Naofumi Mukaida and colleagues at Kanazawa University, Japan, identified a central role for the soluble factor TNF-alpha in the development of colon cancer in mice in which inflammation of the bowel was induced by administration of azoxymethane (AOM) followed by repeated dextran sulfate sodium (DSS) ingestion. Expression of TNF-alpha was increased in the colon of normal mice treated with AOM and DSS and this was followed by the development of tumors in the colon. Mice lacking one of the receptors for TNF-alpha and mice treated with an antagonist of TNF-alpha were markedly protected from the effects of treatment with AOM and DSS, developing less inflammation of the colon and fewer tumors in the colon. As suggested by the authors, and by Ezra Burstein and Eric R. Fearon in an accompanying commentary, these data provide clear rationale for the idea that drugs antagonizing TNF-alpha (such as those used to treat individuals with rheumatoid arthritis) might be useful in reducing the risk of colon cancer in individuals with ulcerative colitis.

###

TITLE: Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis

AUTHOR CONTACT:
Naofumi Mukaida
Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.

ACCOMPANYING COMMENTARY TITLE: Colitis and cancer: a tale of inflammatory cells and their cytokines

AUTHOR CONTACT:
Eric R. Fearon
University of Michigan Medical School, Ann Arbor, Michigan, USA.
Ezra Burstein
University of Michigan Medical School, Ann Arbor, Michigan, USA.

Source: Karen Honey
Journal of Clinical Investigation

Article adapted by Medical News Today from original press release.
Visit our gastrointestinal / gastroenterology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Karen Honey. "Inflammation-Induced Colon Cancer Stopped In Its Tracks By TNF-Alpha Antagonist." Medical News Today. MediLexicon, Intl., 25 Jan. 2008. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/95113.php>

APA
Karen Honey. (2008, January 25). "Inflammation-Induced Colon Cancer Stopped In Its Tracks By TNF-Alpha Antagonist." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/95113.php.

Please note: If no author information is provided, the source is cited instead.




GastroIntestinal / Gastroenterology

What Are Piles?

Piles are hemorrhoids that become inflamed. Hemorrhoids are masses, clumps, cushions of tissue in the anal canal - they are full of blood vessels, support tissue, muscle and elastic fibers. Read more...

Most Popular Articles



Follow Our GastroIntestinal News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our GastroIntestinal / Gastroenterology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »